Search
for
Sort by
Research 30 of 1000+
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- GSK-3 Inhibitors: Recent Developments and Therapeutic Potential
- Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Evaluation of Therapeutic Potential of a Selective 5α-reductase Inhibitor against Glioblastoma: Molecular Docking and In Vitro Insights
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- Therapeutic options for erosive pustular dermatosis of the scalp: a systematic review*
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- The Enticing Path of miR Therapeutics: Difficult but Not without Prospects
- The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications
- Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles
- RANK as a therapeutic target in cancer
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Therapeutic strategies for treating hair loss
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice